14.750
+1,03%
2026-10-19
Fundamental Analysis
28 / 100CRubric: Manufacturing
| Quarterly results | Relative Valuation | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Criterion | Latest Q EPS growth (YoY) | Avg EPS growth, last 3 (YoY) | Quarters with EPS growth | Revenue growth (YoY) | Gross margin change (pp, YoY) | Net margin change (pp, YoY) | Return on Equity (TTM) | Financial health (Debt/Equity) | Valuation (P/E vs 5-yr median) | Revenue (bn) | Rev YoY | NPAT (bn) | NPAT YoY | P/E | 5-Year Median P/E | P/E vs. 5-Year Median |
| Value | -34.0% | -18.4% | 1 / 3 | +11.1% | -1.52 pp | -1.75 pp | +9.4% | 1.30 | 10.82 | 1.007 | +11,1% | 25,8 | −34,0% | 10.82 | 9.70 | +11,5% |
| Pts | 0 | 0 | 4 | 4 | 4 | 4 | 0 | 6 | 8 | |||||||
Valuation annotation:Price: 14.750 (close price on 2026-10-19)EPS (TTM): 1.363
Financial charts
1.Revenue & growth
VND bn1.007Q2/26
1.Revenue & growth
VND bn1.007Q2/26
2.Profit & growth
VND bn25,8Q2/26
3.Profit mix (Penman)
VND bn122Q2/26
4.Margins & cost structure
%11.3%Q2/26
5.Returns & cash cycle
% · days6.4%Q2/26
6.Earnings quality & cash
VND bn267Q2/26
7.Asset structure
VND bn3.047Q2/26
8.Funding & debt health
VND bn · times3.047Q2/26
9.Revenue backlog
VND bn47,9Q2/26
10.Valuation
times · %11,6×Q2/26
11.EPS growth & dilution warning (CANSLIM)
VND per share; growth in %371Q2/26
Adjusted EPS growth, latest quarter
-51.6%
Average adjusted EPS growth, 3 quarters
-44.1%
Quarters at 25%+ growth
0/3
Share dilution rate, 1 year
36.4%
Source: vnstockData through Q2/26